Key result
Percutaneous cardiopulmonary support as an adjunct to thrombolytic therapy was successfully used in a patient with severe pulmonary embolism, with no recurrence of thromboembolism at 2 years.
Why the study?
Does percutaneous cardiopulmonary support (PCPS) improve outcomes in a patient with right ventricular thrombus and acute pulmonary embolism?
Case Report (n=1)
Does percutaneous cardiopulmonary support (PCPS) improve outcomes in a patient with right ventricular thrombus and acute pulmonary embolism?
Percutaneous cardiopulmonary support (PCPS) may serve as an effective adjunct to thrombolytic therapy in high-risk patients with severe pulmonary embolism and right ventricular thrombus.
May support PCPS adjunct in refractory PE with RV thrombus; leaves open confirmation in prospective studies.
The management of patients with acute pulmonary embolism (PE) remains controversial, despite an improved understanding of its pathogenesis and diagnosis. Haemodynamic instability due to right ventricular failure and hypoxia following PE is associated with a high mortality rate. This report describes a case of a 22-year-old woman with leukaemia in which percutaneous cardiopulmonary support (PCPS) was used as an adjunct to thrombolytic therapy in the treatment of right ventricular thrombus with acute PE. The patient has since undergone regular follow-up on an outpatient basis without showing any recurrence of thromboembolism at 2 years postoperatively. This experience suggests that supportive PCPS may provide favourable clinical outcomes in high-risk patients with severe PE.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2002) conducted a case report in Right ventricular thrombus with acute pulmonary embolism (n=1). Percutaneous cardiopulmonary support (PCPS) as an adjunct to thrombolytic therapy was evaluated on Recurrence of thromboembolism. Percutaneous cardiopulmonary support as an adjunct to thrombolytic therapy was successfully used in a patient with severe pulmonary embolism, with no recurrence of thromboembolism at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: